CN102935199A - Chinese medicinal composition for treating chronic gastritis - Google Patents
Chinese medicinal composition for treating chronic gastritis Download PDFInfo
- Publication number
- CN102935199A CN102935199A CN2012104891148A CN201210489114A CN102935199A CN 102935199 A CN102935199 A CN 102935199A CN 2012104891148 A CN2012104891148 A CN 2012104891148A CN 201210489114 A CN201210489114 A CN 201210489114A CN 102935199 A CN102935199 A CN 102935199A
- Authority
- CN
- China
- Prior art keywords
- grams
- chronic gastritis
- stomach
- composition
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000007882 Gastritis Diseases 0.000 title claims abstract description 19
- 208000023652 chronic gastritis Diseases 0.000 title claims abstract description 17
- 239000000203 mixture Substances 0.000 title claims abstract description 12
- 239000003814 drug Substances 0.000 claims abstract description 24
- 241000218176 Corydalis Species 0.000 claims abstract description 5
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- 210000003038 endothelium Anatomy 0.000 claims description 4
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 4
- 208000002193 Pain Diseases 0.000 abstract description 17
- 230000036407 pain Effects 0.000 abstract description 17
- 210000000952 spleen Anatomy 0.000 abstract description 17
- 210000002784 stomach Anatomy 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 11
- 208000024891 symptom Diseases 0.000 abstract description 11
- 206010067171 Regurgitation Diseases 0.000 abstract description 7
- 230000001105 regulatory effect Effects 0.000 abstract description 7
- 206010061428 decreased appetite Diseases 0.000 abstract description 6
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 239000002253 acid Substances 0.000 abstract description 5
- 208000022531 anorexia Diseases 0.000 abstract description 5
- 230000004087 circulation Effects 0.000 abstract description 5
- 235000019789 appetite Nutrition 0.000 abstract description 2
- 230000036528 appetite Effects 0.000 abstract description 2
- 230000029087 digestion Effects 0.000 abstract description 2
- 241001127714 Amomum Species 0.000 abstract 1
- 241000237528 Arcidae Species 0.000 abstract 1
- 244000080767 Areca catechu Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 235000008671 Calycanthus floridus Nutrition 0.000 abstract 1
- 235000008670 Calycanthus occidentalis Nutrition 0.000 abstract 1
- 244000183685 Citrus aurantium Species 0.000 abstract 1
- 235000007716 Citrus aurantium Nutrition 0.000 abstract 1
- 240000004307 Citrus medica Species 0.000 abstract 1
- 206010015137 Eructation Diseases 0.000 abstract 1
- 241000287828 Gallus gallus Species 0.000 abstract 1
- 244000148992 Lindera benzoin Species 0.000 abstract 1
- 235000004520 Lindera benzoin Nutrition 0.000 abstract 1
- 235000008262 Lindera benzoin var. benzoin Nutrition 0.000 abstract 1
- 244000179970 Monarda didyma Species 0.000 abstract 1
- 235000010672 Monarda didyma Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000272264 Saussurea lappa Species 0.000 abstract 1
- 235000006784 Saussurea lappa Nutrition 0.000 abstract 1
- 208000020560 abdominal swelling Diseases 0.000 abstract 1
- 208000027687 belching Diseases 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 14
- 235000013305 food Nutrition 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 7
- 206010047700 Vomiting Diseases 0.000 description 7
- 208000026435 phlegm Diseases 0.000 description 7
- 239000007788 liquid Substances 0.000 description 6
- 230000008673 vomiting Effects 0.000 description 6
- 210000001015 abdomen Anatomy 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 201000006549 dyspepsia Diseases 0.000 description 5
- 206010000077 Abdominal mass Diseases 0.000 description 4
- 210000000038 chest Anatomy 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 206010016766 flatulence Diseases 0.000 description 3
- 235000019525 fullness Nutrition 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 206010025482 malaise Diseases 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 208000037920 primary disease Diseases 0.000 description 3
- 230000004206 stomach function Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000012895 Gastric disease Diseases 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 235000021152 breakfast Nutrition 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 208000007565 gingivitis Diseases 0.000 description 2
- 208000024798 heartburn Diseases 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 238000009738 saturating Methods 0.000 description 2
- 208000018556 stomach disease Diseases 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- GHOKWGTUZJEAQD-SSDOTTSWSA-N 3-[[(2s)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]propanoic acid Chemical compound OCC(C)(C)[C@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-SSDOTTSWSA-N 0.000 description 1
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- AEQDJSLRWYMAQI-UHFFFAOYSA-N Tetrahydropalmatine Natural products C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000002575 gastroscopy Methods 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 description 1
- 229960000620 ranitidine Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 230000036301 sexual development Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- AEQDJSLRWYMAQI-KRWDZBQOSA-N tetrahydropalmatine Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3C[C@H]2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-KRWDZBQOSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses a Chinese medicinal composition for treating chronic gastritis. The composition is prepared from the following raw medicaments by weight: 6 grams of bergamot, 6 grams of amomum, 6 grams of rhizoma corydalis, 6 grams of chicken's gizzard-membrane, 6 grams of costus root, 10 grams of immature bitter orange, 10 grams of citron peel, 10 grams of areca peel, 10 grams of rhizoma cyperi, 15 grams of bighead atractylodes rhizome, 15 grams of poria cocos, 20 grams of ark shell, and 20 grams of root of three-nerved spicebush. The composition has the effects of normalizing stomach, tonifying spleen, promoting qi circulation to relieve pain, invigorating spleen, regulating the middle warmer, helping digestion and promoting appetite, can quickly and effectively relieve the symptoms of upper abdominal swelling, belching, acid regurgitation, anorexia and the like and improve other clinical symptoms, is exact in curative effect, and does not have toxic or side effect.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation, be specially a kind of Chinese medicine composition for the treatment of chronic gastritis.
Background technology
Chronic gastritis is a kind of common frequently-occurring disease, and its sickness rate occupies first of the various gastropathy, and the age is larger, and sickness rate is higher, and men and women, old and young all can suffer from, and the course of disease is long, and easily recurrence is very large to health effect.Its pathological process, to atrophy, is and carries out sexual development by shallow table to heavy by gently.The modal symptom of primary disease is stomach pain and feeling of repletion, sx↑ especially after the meal, and pleasant on an empty stomach.Though each food-intake is few, feel satiety and uncomfortable, often with phenomenons such as belch, acid regurgitation, heartburn, nausea and vomiting, inappetence, dyspepsias.
For the treatment of chronic gastritis, although the instant effect that has Western medicine, Western medicine is eaten for a long time and can be developed immunity to drugs, and have more untoward reaction to occur, and treatment cost is high, and curative effect is undesirable, and relapse rate is high.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine composition for the treatment of chronic gastritis, this medicine can be alleviated the symptoms such as epigastric distension and distress, stomachache, belch, acid regurgitation rapidly, effectively, and improves other clinical symptoms, improves the adverse effect that primary disease brings the patient.
The technical scheme that technical solution problem of the present invention is taked is: a kind of Chinese medicine composition for the treatment of chronic gastritis, it is characterized in that, and made by the crude drug of following weight: Fructus Citri Sarcodactylis 6 grams, Fructus Amomi 6 grams, Rhizoma Corydalis 6 grams, Endothelium Corneum Gigeriae Galli 6 grams, the Radix Aucklandiae 6 grams, Fructus Aurantii Immaturus 10 grams, Pericarpium Citri 10 grams, Pericarpium Arecae 10 grams, Rhizoma Cyperi 10 grams, the Rhizoma Atractylodis Macrocephalae 15 grams, Poria 15 grams, Concha Arcae 20 grams, the Radix Linderae 20 grams.
Preparation and instructions of taking: raw material is mixed in the marmite, adds blister saturating; Elder generation's intense fire is fried boiling, and with half an hour at a simmer, leaches medicinal liquid again, adds water in the medicinal residues and fries in shallow oil half an hour, leaches medicinal liquid again.Twice medicinal liquid mixes, cools completely, and respectively at half an hour before the breakfast, takes in two hours after the supper.Ten days is a course for the treatment of.
Pharmacological action:
Fructus Citri Sarcodactylis: regulate the flow of vital energy, reduce phlegm, treat for stomachache, the side of body is swollen, and vomiting is dysphagic, the phlegm retention cough with asthma.
Fructus Amomi: suffering, temperature.Enter spleen, stomach warp.During circulation of qi promoting was transferred, stomach function regulating was amusing.Control the stomachache painful abdominal mass swollen, anorexia dyspepsia, dysphagic vomiting, diarrhea due to cold pathogen cold-dysentery, pregnant fetal movement.
Rhizoma Corydalis: hot, bitter, temperature.Return liver, the heart, stomach warp.Activating blood circulation to dissipate blood stasis, promoting the circulation of QI to relieve pain are apt to control inside and outside all pains, are widely used in obstruction of qi in the chest and cardialgia, stomachache due to hyperactive liver-QI attacking the stomach, dysmenorrhea, gather stomachache, treating swelling and pain by traumatic injury, bones and muscles pain.Studies confirm that: this product contains the compositions such as tetrahydropalmatine, has calmness, analgesic activity.
Endothelium Corneum Gigeriae Galli: removing food stagnancy stagnates, strengthening the spleen and stomach.Control the food stagnation distension, vomiting regurgitation, dysentery, infantile malnutrition is quenched one's thirst, incontinence of urine, sore throat tonsillitis, ulcerative gingivitis aphtha.
The Radix Aucklandiae: gas fragrance, distinguish the flavor of sweet, bitter, slightly sting tongue.Warm in nature, acrid in the mouth, hardship.Promoting the circulation of QI to relieve pain, strengthening the spleen to promote digestion.Be used for heavy behind breast gastral cavity distending pain, the dysentery, food stagnation does not disappear, anorexia.
Fructus Aurantii Immaturus: hardship, cold.Enter spleen, stomach warp.Dispelling the stagnated QI, loose painful abdominal mass is rushed down expectorant, removing food stagnancy.Control distension and fullness of the chest and abdomen, the thoracic obstruction, painful abdominal mass pain, accumulation of phlegm in the hypochondrium, edema, food stagnation, constipation, gastroptosis, uterine prolapse, proctoptosis.
Pericarpium Citri: hot, bitter, sour, temperature.Enter liver, lung, spleen channel.Regulate the flow of vital energy Shu Yu, expectorant, sharp diaphragm.The distension that treats for stomachache, cough due to fluid-retention gas is moulded, the few food of the sound of vomiting of vomitting.
Pericarpium Arecae: therapeutic method to keep the adverse QI flowing downwards alleviating distention in middle-JIAO, eliminating the pathogens from the lung in the accent, easing stomach-QI, row water.Control gastral cavity abdomen painful abdominal mass swollen, logical intestine and small intestine, spleen benefiting and stimulating the appetite, dampness removing chases after wind, wide intestinal detumescence.
Rhizoma Cyperi: the resolving depression of regulating the flow of vital energy, pain relieving regulating menstruation.The treating the liver discomfort in the stomach, depression of QI, breast abdomen distending pain over the hypochondrium, phlegm retention feeling of fullness, menoxenia.
The Rhizoma Atractylodis Macrocephalae: spleen reinforcing, stomach reinforcing, dampness, and in.Control deficient QI of the spleen and stomach, anorexia asthenia weak breath, deficiency-distension is had loose bowels, edema, jaundice, arthralgia chiefly caused by damp pathogen, dizziness, spontaneous perspiration.
Poria: sweet light, flat.Enter the heart, spleen, lung meridian.Eliminating dampness and diuresis, strengthening the spleen stomach function regulating, mind tranquilizing and the heart calming.Control dysuria, the edema distension, the phlegm retention cough with dyspnea, the sound of vomiting of vomitting is had loose bowels, seminal emission, stranguria with turbid discharge, palpitation with fear, forgetful.
Concha Arcae: reduce phlegm softening the hard mass, dissipating blood stasis, removing food stagnancy.Control accumulation of phlegm, stomachache, noisy, acid regurgitation ， mass in the abdomen, scrofula, ulcerative gingivitis.
The Radix Linderae: pleasant, dissipating depression of QI, cold expelling, pain relieving.Control the QI rising in reverse order chest and abdomen swelling and pain, dyspepsia does not disappear, and food is told in regurgitation, colic of cold type.
The traditional Chinese medical science thinks that chronic gastritis belongs to the sick category such as the gastric abscess of Chinese medicine, feeling of fullness, the many emptiness of spleen and stomach owing to body of the etiology and pathogenesis of chronic gastritis, and inside and outside heresy is taken advantage of and is attacked it in addition, mainly contain and both make the mechanism of qi retardance, be again the turbid source of expectorant, with the passing of time insufficiency of the spleen, then become the taste cold-damp.For the etiology and pathogenesis of primary disease, the treatment chronic gastritis should be with warming YANG and strengthening body resistance, and function of spleen and stomach regulating is basic principle.
After the present invention makes up said medicine, its drug effect has synergism, it is reasonable that this kind treated the Chinese medicine composition composition formula of chronic gastritis, easy to prepare, have stomach function regulating spleen invigorating, promoting the circulation of QI to relieve pain, spleen invigorating and in, the effect of digesting and appetizing, can rapidly, effectively alleviate the symptoms such as epigastrium feeling of distension and oppression, belch, acid regurgitation, loss of appetite, and improve other clinical symptoms, determined curative effect and having no side effect.
The invention has the beneficial effects as follows: the present invention is through 150 many cases chronic gastritis clinical research confirmations, total effective rate 100%, cure rate 94.0%(cures 141 examples).The present invention has overcome and has taken the side effect that Western medicine causes, has reduced the generation of untoward reaction, and improves the human body autoimmune function, and key has suppressed the generation of complication, reaches treating both the principal and secondary aspects of a disease, has no side effect.
Model case
Case one, Su Liya, the woman, 28 years old, stomach pain was more than 2 years, and have a stomach-ache during morbidity flatulence, burn feeling increase the weight of after the meal.The patient is multi-treatment once, but poor effect.Serve on two courses for the treatment of of medicine of the present invention, pain relief, but still feel and continue sometimes flatulence to take medicine two courses for the treatment of, the flatulence that has a stomach-ache disappears, and gastritis has obtained recovery from illness, and Effect of follow-up visit by telephone has no recurrence.
Case two: Sun Meiyun, woman, 38 years old.The patient suffered from chronic gastritis more than five years, recently increase the weight of, show as gastral cavilty section pain and be persistence, with pantothenic acid, vomiting, take the medicines such as ranitidine, losec and can make remission, but immediately recurrence after the drug withdrawal, by taking medicine of the present invention after three courses for the treatment of, the symptom complete obiteration continues to strengthen course for the treatment of of treatment, transference cure, fully recover, follow up a case by regular visits to and have no recurrence.
Case three, Wang Liwu, man, 49 years old.The patient is the gastropathy history for many years, and the year before gastroscopy is chronic gastritis, and clinical symptoms to be having a stomach-ache as main, the diseases such as companion's pantothenic acid, heartburn, retch, constipation, and going too much, hospital of family all thoroughly cures.Through taking Drug therapy of the present invention after two courses for the treatment of, pain relief, serve on four courses for the treatment of after gastroscope check inflammation disappear, fully recover, follow up a case by regular visits to not wind recurrence.
Case four: Wang Benjin, man, 56 years old.Patient's gastralgia, both sides of the chest distending pain, and with anorexia, become thin, the disease such as anemia.Removing hospital diagnosis is chronic gastritis, takes multi-medicament, heavy when light during symptom, repeatedly outbreak.The patient is through taking the Chinese medicine of the present invention alleviation that has a stomach-ache after two courses for the treatment of, continue to strengthen treatment three courses for the treatment of after, the general malaise symptom thoroughly disappears, gastroscope check gastritis disappears, the patient continues to take medicine course for the treatment of of after treatment, has reached thorough clinical cure, and drug withdrawal is so far again without repeatedly.
The specific embodiment
Embodiment 1
Prescription: Fructus Citri Sarcodactylis 6 grams, Fructus Amomi 6 grams, Rhizoma Corydalis 6 grams, Endothelium Corneum Gigeriae Galli 6 grams, the Radix Aucklandiae 6 grams, Fructus Aurantii Immaturus 10 grams, Pericarpium Citri 10 grams, Pericarpium Arecae 10 grams, Rhizoma Cyperi 10 grams, the Rhizoma Atractylodis Macrocephalae 15 grams, Poria 15 grams, Concha Arcae 20 grams, the Radix Linderae 20 grams.
Preparation and instructions of taking: raw material is mixed in the marmite, adds blister saturating; Elder generation's intense fire is fried boiling, and with half an hour at a simmer, leaches medicinal liquid again, adds water in the medicinal residues and fries in shallow oil half an hour, leaches medicinal liquid again.Twice medicinal liquid mixes, cools completely, and respectively at half an hour before the breakfast, takes in two hours after the supper.Ten days is a course for the treatment of.
Claims (1)
1. a Chinese medicine composition for the treatment of chronic gastritis is characterized in that, is made by the crude drug of following weight: Fructus Citri Sarcodactylis 6 grams, Fructus Amomi 6 grams, Rhizoma Corydalis 6 grams, Endothelium Corneum Gigeriae Galli 6 grams, the Radix Aucklandiae 6 grams, Fructus Aurantii Immaturus 10 grams, Pericarpium Citri 10 grams, Pericarpium Arecae 10 grams, Rhizoma Cyperi 10 grams, the Rhizoma Atractylodis Macrocephalae 15 grams, Poria 15 grams, Concha Arcae 20 grams, the Radix Linderae 20 grams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012104891148A CN102935199A (en) | 2012-11-27 | 2012-11-27 | Chinese medicinal composition for treating chronic gastritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012104891148A CN102935199A (en) | 2012-11-27 | 2012-11-27 | Chinese medicinal composition for treating chronic gastritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102935199A true CN102935199A (en) | 2013-02-20 |
Family
ID=47694146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012104891148A Pending CN102935199A (en) | 2012-11-27 | 2012-11-27 | Chinese medicinal composition for treating chronic gastritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102935199A (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103536874A (en) * | 2013-10-08 | 2014-01-29 | 覃祖仁 | Medicine for treating superficial gastritis |
| CN103623171A (en) * | 2013-11-15 | 2014-03-12 | 王芬 | Traditional Chinese medicine composition for treating chronic gastritis |
| CN104147492A (en) * | 2014-07-18 | 2014-11-19 | 甘保明 | Traditional Chinese medicine composition for treating superficial gastritis |
| CN104288745A (en) * | 2014-10-30 | 2015-01-21 | 范鹏琳 | Traditional Chinese medicine for treating CG (Chronic Gastritis) |
| CN104524414A (en) * | 2014-12-26 | 2015-04-22 | 山东明仁福瑞达制药股份有限公司 | Traditional Chinese medicine preparation for treating chronic gastritis |
| CN104606471A (en) * | 2015-02-15 | 2015-05-13 | 赵世明 | Traditional Chinese medicine composition for treating chronic gastritis |
| CN104800744A (en) * | 2015-05-25 | 2015-07-29 | 合肥丰瑞隆生物科技有限公司 | Traditional Chinese medicine for treating gastritis |
| CN104922546A (en) * | 2015-06-12 | 2015-09-23 | 广西大学 | Traditional Chinese medicine composition curing chronic gastritis and preparation method thereof |
| CN106581556A (en) * | 2016-12-21 | 2017-04-26 | 珠海横琴新区德群中医药科学研究院有限公司 | Traditional Chinese medicine composition for treating gastric mucosal lesions |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1362257A (en) * | 2001-12-26 | 2002-08-07 | 邹明义 | Gastrosis treating Chinese medicine prepn. |
| CN101244248A (en) * | 2008-02-02 | 2008-08-20 | 孟德芹 | Method of preparing traditional Chinese medicine for treating chronic superficial gastritis |
| CN101279072A (en) * | 2008-05-30 | 2008-10-08 | 连德峰 | Chinese medicine capsule for curing digestive system disease |
| CN101700337A (en) * | 2009-11-16 | 2010-05-05 | 张晨 | Oral traditional Chinese medicine composition for treating chronic gastritis |
| CN102091282A (en) * | 2011-03-25 | 2011-06-15 | 路正平 | Medicament for treating chronic gastritis and gastric ulcer |
-
2012
- 2012-11-27 CN CN2012104891148A patent/CN102935199A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1362257A (en) * | 2001-12-26 | 2002-08-07 | 邹明义 | Gastrosis treating Chinese medicine prepn. |
| CN101244248A (en) * | 2008-02-02 | 2008-08-20 | 孟德芹 | Method of preparing traditional Chinese medicine for treating chronic superficial gastritis |
| CN101279072A (en) * | 2008-05-30 | 2008-10-08 | 连德峰 | Chinese medicine capsule for curing digestive system disease |
| CN101700337A (en) * | 2009-11-16 | 2010-05-05 | 张晨 | Oral traditional Chinese medicine composition for treating chronic gastritis |
| CN102091282A (en) * | 2011-03-25 | 2011-06-15 | 路正平 | Medicament for treating chronic gastritis and gastric ulcer |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103536874A (en) * | 2013-10-08 | 2014-01-29 | 覃祖仁 | Medicine for treating superficial gastritis |
| CN103623171A (en) * | 2013-11-15 | 2014-03-12 | 王芬 | Traditional Chinese medicine composition for treating chronic gastritis |
| CN104147492A (en) * | 2014-07-18 | 2014-11-19 | 甘保明 | Traditional Chinese medicine composition for treating superficial gastritis |
| CN104288745A (en) * | 2014-10-30 | 2015-01-21 | 范鹏琳 | Traditional Chinese medicine for treating CG (Chronic Gastritis) |
| CN104524414A (en) * | 2014-12-26 | 2015-04-22 | 山东明仁福瑞达制药股份有限公司 | Traditional Chinese medicine preparation for treating chronic gastritis |
| CN104606471A (en) * | 2015-02-15 | 2015-05-13 | 赵世明 | Traditional Chinese medicine composition for treating chronic gastritis |
| CN104800744A (en) * | 2015-05-25 | 2015-07-29 | 合肥丰瑞隆生物科技有限公司 | Traditional Chinese medicine for treating gastritis |
| CN104922546A (en) * | 2015-06-12 | 2015-09-23 | 广西大学 | Traditional Chinese medicine composition curing chronic gastritis and preparation method thereof |
| CN106581556A (en) * | 2016-12-21 | 2017-04-26 | 珠海横琴新区德群中医药科学研究院有限公司 | Traditional Chinese medicine composition for treating gastric mucosal lesions |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102895603B (en) | Chinese herbal medicine for treating gastro-intestinal diseases | |
| CN103705843B (en) | A kind of medicine for the treatment of gastropathy | |
| CN102764403B (en) | Traditional Chinese medicine for treating chronic gastritis and gastroduodenal ulcer | |
| CN104225441A (en) | Traditional Chinese medicine composition for treating stomach trouble and preparation method of granules and capsules of traditional Chinese medicine composition | |
| CN104225493A (en) | Traditional Chinese medicine for treating gallstone | |
| CN101791384B (en) | Chinese patent medicine for treating infantile malnutrition of infants | |
| CN104069162B (en) | A kind of Chinese medicine for treating urarthritis and various bone joint pains | |
| CN103536881A (en) | Drug for treating chronic gastritis | |
| CN104107398A (en) | Traditional Chinese medicine composition for treating rheumatic heart disease | |
| CN103212020B (en) | Traditional Chinese medicine composition for treating functional dyspepsia | |
| CN103239682A (en) | Medicament for treating chronic gastritis | |
| CN103006980B (en) | Chinese medicinal composition for treating distention and fullness | |
| CN105497803A (en) | Nutrition and health care porridge | |
| CN101700337B (en) | Oral traditional Chinese medicine composition for treating chronic gastritis | |
| CN101780259B (en) | Traditional Chinese medicine for treating gastric cancer | |
| CN101204565B (en) | Peroral Chinese traditional medicine prescripton for superficial gastritis | |
| CN103623171A (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
| CN102423414B (en) | External Chinese medicinal preparation for treating cold-accumulation and qi-stagnation stomachache | |
| CN104337955A (en) | Traditional Chinese medicine formula applied to treatment of liver cancer and preparation method of traditional Chinese medicine formula | |
| CN103735997B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of gastric cancer | |
| CN101884738A (en) | Chinese medicinal composition for treating panasthenia | |
| CN102247502B (en) | Traditional Chinese medicine composition for treating breast cancer and preparation method thereof | |
| CN109700995B (en) | A pharmaceutical composition for treating peptic ulcer, and its preparation method | |
| CN107854662A (en) | A kind of Chinese medicine preparation for treating cirrhotic ascites and preparation method thereof | |
| CN106822852A (en) | Treat pharmaceutical composition, its preparation technology and the purposes of coronary heart disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130220 |